| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chair of the Board & CEO
3 companies
Donald E Morel Jr. is Chair of the Board & CEO at WST and has filed Form 4s across 3 companies. Donald E Morel Jr.'s net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $316.4M at current prices.
The biggest single holding is WST (~$315.1M) as Chair of the Board & CEO. The WST filings lean toward selling, a net 40,000 shares.
Donald E Morel Jr. has 17 Form 4 filings on record from January 2015 to June 2026, across 3 companies: Director at Stevanato Group S.p.A. (STVN), 2026; Director at Integra Lifesciences (IART), 2015–2022; Chair of the Board & CEO at West Pharmaceutical Services (WST), 2015.
The 22 reported transactions were 12 stock awards, 4 open-market sales, 3 gifts and 2 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $492K and 3 sales worth about $2.2M.
The only open-market purchase was 10,000 shares of IART at an average $49.25 on August 4, 2017, about $492K.
The largest open-market sale was 20,000 shares of WST at an average $54.49 on May 29, 2015, about $1.1M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | STVN Stevanato Group S.p.a. | Director | Sell | 1,493 | $17.09 | $25,515.37 | -3.8% | +28.2% | - | |
| Aug 4, 2017 | IART Integra Lifesciences Holdings Corp | Director | Buy | 10,000 | $49.25 | $492,457.50 | +36.9% | - | - | |
| May 29, 2015 | WST West Pharmaceutical Services Inc | Chair of the Board & CEO | Sell | 20,000 | $54.49 | $1,089,716.00 | -2.5% | - | - | |
| May 15, 2015 | WST West Pharmaceutical Services Inc | Chair of the Board & CEO | Sell | 20,000 | $54.29 | $1,085,709.00 | -2.5% | - | - |